A new treatment could help leukaemia patients who are too weak for chemotherapy, according to a new study.
Scientists at the University of Birmingham said using a combination of the contraceptive pill and a cholesterol-lowering drug could be a safer and more effective option for patients.Some 20 acute myeloid leukaemia (AML) patients treated with Bezafibrate and the female contraceptive drug Medroxyprogesterone Acetate suffered none of the side effects linked with chemotherapy, the scientists said.
For the full story visit the Nursing Times Webpage by clicking HERE.
Always good to hear about new less aggresssive treatments being developed.This research, i am lead to believe,was funded by Leukaemia Research.
.
No comments:
Post a Comment